Tags:

U.S. Appeals Court Upholds $442.2 Mln Plavix Award

Tuesday, 18 Oct 2011 08:23 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

(Reuters) - A U.S. appeals court upheld a ruling requiring Apotex Inc to pay Sanofi and Bristol-Myers $442 million for infringing a patent for the blood thinner Plavix but tossed out $108 million in interest on Tuesday.

The U.S. Court of Appeals for the Federal Circuit, which hears most appeals related to patents, ruled that Apotex, a privately held Canadian drugmaker, was required to pay the damages but that the lower court erred in awarding prejudgment interest.

Apotex briefly sold a generic version of Plavix in a so-called at risk launch, while challenging the validity of a patent for the anti-clot drug used to prevent heart attacks and strokes.

But a court ruled that the Canadian company had infringed the patent and forced Apotex to stop selling its version.

Plavix, known generically as clopidogrel bisulfate, generated $1.87 billion in sales during the second quarter, underscoring the importance of the medicine to Bristol-Myers and French partner Sanofi.

The patent for Plavix expires in May 2012.

Sanofi and Bristol-Myers Squibb said in a statement that while they were pleased with the damages award, they were disappointed with the court's decision with respect to the prejudgment interest.

The case had come from the U.S. District Court for the Southern District of New York, which had issued the order for Apotex to pay the $442 million in damages plus additional interest in October 2010.

Litigation in the case goes back to March 2002. Sanofi is based in Paris, and Bristol-Myers in New York.

The Federal Circuit case is Sanofi-Aventis et al v. Apotex Inc et al. No. 2011-1048

The underlying case is Sanofi-Aventis et al v. Apotex Inc et al, U.S. District Court, Southern District of New York, No. 02-02255. (Reporting by Diane Bartz in Washington, D.C.)

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Ebola Vaccines Carry Downsides as Makers Rush to Trials

Tuesday, 21 Oct 2014 13:41 PM

Each of the Ebola vaccines being lined up for testing carries potential downsides, researchers say, ranging from efficac . . .

Mack McLarty: Obama Can Salvage Final Years in Office

Tuesday, 21 Oct 2014 13:32 PM

President Obama could accomplish much in his final two years in office despite widespread doubts and discontent about hi . . .

Sen. Leahy Urges Comcast to Extend Net Neutrality Pledge

Tuesday, 21 Oct 2014 12:40 PM

Vermont Sen. Patrick Leahy, the chairman of the Judiciary Committee, has called on Comcast to extend its net neutrality  . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved